Details for New Drug Application (NDA): 203166
✉ Email this page to a colleague
The generic ingredient in NABUMETONE is nabumetone. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the nabumetone profile page.
Summary for 203166
Tradename: | NABUMETONE |
Applicant: | Lgm Pharma |
Ingredient: | nabumetone |
Patents: | 0 |
Pharmacology for NDA: 203166
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 203166
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NABUMETONE | nabumetone | TABLET;ORAL | 203166 | ANDA | Carwin Pharmaceutical Associates, LLC | 15370-170 | 15370-170-10 | 100 TABLET in 1 BOTTLE, PLASTIC (15370-170-10) |
NABUMETONE | nabumetone | TABLET;ORAL | 203166 | ANDA | Carwin Pharmaceutical Associates, LLC | 15370-170 | 15370-170-30 | 30 TABLET in 1 BOTTLE, PLASTIC (15370-170-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Aug 30, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 750MG | ||||
Approval Date: | Aug 30, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
Approval Date: | Aug 30, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription